Back to my company list

New

Trial Genasys

The AI engine Fit Assessment

Beta

The company develops AI-driven pharmaceutical tech solutions for drug discovery and clinical trial optimization, serving biotech and pharmaceutical innovators and integrating regulatory expertise to improve operations.

Blurb

Developer of AI-driven solutions for drug discovery and clinical trial processes. The company integrates technology with regulatory expertise to improve operational workflows in the biotech and pharmaceutical sectors, serving drug developers and clinical researchers. Their offerings address regulatory complexities and enhance efficiency in clinical research.

HQ Location

Princeton (United States)

Founded

2025

Employees

1 - 10

Total funding raised

Not available

Funding Status

Not available

We believe that every breakthrough in medicine begins with a bold question: ‘What if?’ What if we could accelerate drug discovery? What if we could eliminate inefficiencies in clinical trials? What if we could empower scientists to create life-saving treatments faster?

At Trial Genasys, our AI solutions are built with one purpose—to help biotech and pharmaceutical innovators transform possibilities into realities. We exist because patients deserve better, because time matters, and because the future of healthcare depends on technology that works for humanity.